Skip to main content

Table 2 Percentages of relative homologous and heterologous seroneutralization titers

From: Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions

Immunised serum

BTV serotype

BTV1

BTV2

BTV4

BTV8

BTV9

BTV16

Control

0.52

1.11

0.55

0.44

0

3.54

BTV1

100

1.11

8.85

25

0

3.54

BTV2

1.3

100

3.15

0.44

0

3.54

BTV4

0.65

0.88

100

0.44

0

12.5

BTV8

10.36

12.5

25

100

6.25

3.54

BTV9

2.61

3.1

0.77

0.44

100

3.54

BTV16

18.34

12.39

0.83

0.44

0

100